| STRAX | VIVIX | STRAX / VIVIX | |
| Total Expense Ratio | 0.69 | 0.03 | 2,300% |
| Annual Report Gross Expense Ratio | 0.80 | 0.03 | 2,667% |
| Fund Existence | 8 years | 28 years | - |
| Gain YTD | 18.913 | 14.777 | 128% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 10000000 | 5000000 | 200% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 77.2M | 245B | 0% |
| Annual Yield % from dividends | 1.31 | 1.88 | 70% |
| Returns for 1 year | 31.94 | 22.78 | 140% |
| Returns for 3 years | 91.84 | 54.03 | 170% |
| Returns for 5 years | 102.86 | 58.49 | 176% |
| Returns for 10 years | N/A | 158.70 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| FSCHX | 14.68 | 0.19 | +1.31% |
| Fidelity Select Chemicals | |||
| MFWLX | 17.93 | 0.19 | +1.07% |
| MFS Global Total Return R6 | |||
| GSPAX | 20.03 | 0.03 | +0.15% |
| Goldman Sachs US Eq Div and Premium A | |||
| BSPAX | 869.26 | 0.03 | N/A |
| iShares S&P 500 Index Investor A | |||
| TRCLX | 19.10 | -0.80 | -4.02% |
| T. Rowe Price China Evolution Equity I | |||